Search

Your search keyword '"Ian Menown"' showing total 7 results
Start Over Author "Ian Menown" Publisher elsevier bv
7 results on '"Ian Menown"'

3. Aborted infarction: the ultimate myocardial salvage

Author

Peter Clemmensen, Per Johanson, Lauren Dowdy, Galen S. Wagner, Ian Menown, Yuling Fu, Maria Sejersten, Yochai Birnbaum, Dwayne Young, and Charles Maynard

Subjects
medicine.medical_specialty, business.industry, Internal medicine, Cardiology, medicine, Infarction, Cardiology and Cardiovascular Medicine, medicine.disease, business
Published
2004
Full Text
View/download PDF

4. TCT-178 Primary Endpoint Results from the TAXUS Element Post-Approval Surveillance Study (TE-PROVE): 1-Year Outcomes in Unselected Patients Treated With a Thin-Strut, Platinum-Chromium, Paclitaxel-Eluting Stent

Author

Davide Capodanno, Andrejs Erglis, Timothy J Gilbert, Raul Moreno, Guillame Lecoq, Ian Menown, Keith D. Dawkins, Corrado Tamburino, Dominic J. Allocco, and Iván Horváth

Subjects
medicine.medical_specialty, Surveillance study, biology, business.industry, medicine.medical_treatment, Stent, chemistry.chemical_element, biology.organism_classification, Surgery, chemistry.chemical_compound, Chromium, Paclitaxel, chemistry, Taxus, medicine, Clinical endpoint, business, Cardiology and Cardiovascular Medicine
Published
2013
Full Text
View/download PDF

5. TCT-262 Comparable low rates of MACE between patients with ST-segment elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) patients in the 12-month follow-up of the e-BioMatrix registry

Author

Keith G. Oldroyd, Ian Menown, Franz X. Kleber, Philip Urban, David Hildick-Smith, Jacques Berland, Marco Roffi, Mariano Valdés, Franz R. Eberli, Imad A. Alhaddad, and David G. Iosseliani

Subjects
medicine.medical_specialty, business.industry, Elevation, medicine.disease, Non stemi, Internal medicine, Cardiology, medicine, ST segment, Myocardial infarction, business, Cardiology and Cardiovascular Medicine, Mace, Month follow up
Published
2013
Full Text
View/download PDF

6. COMPARISON OF HEALTH AND ECONOMIC OUTCOMES OF NEW ORAL ANTICOAGULANTS FOR THE PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN ATRIAL FIBRILLATION

Author

Sonja V. Sorensen, Ian Menown, Ying Zheng, Eva Kleine, Ray Ghouse, Anuraag R. Kansal, Jutta Heinrich-Nols, and Ann-Katrin Gonschior

Subjects
medicine.medical_specialty, Rivaroxaban, business.industry, Atrial fibrillation, Systemic embolism, medicine.disease, Dabigatran, chemistry.chemical_compound, chemistry, Edoxaban, Internal medicine, Cardiology, Medicine, Apixaban, Cardiology and Cardiovascular Medicine, business, Stroke, medicine.drug
Abstract

In the past five years, four new oral anticoagulants (NOACs) - dabigatran, rivaroxaban, apixaban and edoxaban - became available for prevention of stroke and systemic embolism among atrial fibrillation (AF) patients. This study compares the health and economic outcomes for AF patients treated with

Published
2016
Full Text
View/download PDF

7. TCT-690 Safety and Clinical Efficacy of Sideguard® Stent for Treatment of Bifurcation Lesions: Interim Results from the European Sideguard® Bifurcation Registry Study

Author

Fraser N. Witherow, Ever D Grech, Javed Iqbal, Simon Eccleshall, Farzin Fath-Ordoubadi, Karl-Eugen Hauptmann, Mohan U. Sivananthan, Mamas A. Mamas, Ian Menown, Joseph D. Mills, Nicos Spyrou, Mohaned Egred, Sanjay Sastry, and Azeem Latib

Subjects
medicine.medical_specialty, business.industry, medicine.medical_treatment, Interim, Registry study, medicine, Stent, Clinical efficacy, Radiology, business, Cardiology and Cardiovascular Medicine, Surgery
Published
2012
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results